Danaher Accelerates Life Sciences Research with New AI-powered Autonomous Lab
Article excerpt
Highlighted: the sentence this signal was extracted from
Helping researchers to move from discovery to breakthrough up to 8x faster by combining AI, automation and innovation from across Danaher's ecosystem of industry-leading technologies WASHINGTON, Oct. 7, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR ) today announced plans to launch its first AI-powered autonomous lab, designed to help researchers develop custom antibodies and other molecular tools faster and more efficiently. Expected to operate at scale in early 2027, the lab will combine artificial intelligence, robotics and technologies from several Danaher operating companies in one connected workflow. It is the first step in a broader Danaher initiative to create smart instruments, integrated workflows and autonomous labs that accelerate scientific research. Danaher's first AI-powered autonomous lab is designed to deliver: "The autonomous lab reflects the kind of progress Danaher is uniquely positioned to deliver," said Julie Sawyer Montgomery, President and Chief Executive Officer of Danaher. "By applying our science, technology and culture of continuous improvement, we can help turn promising ideas into validated systems faster. It is an important step toward a future where AI, automation and intelligent systems dramatically accelerate the journey from discovery to impact." Based at Abcam, a Danaher company, the lab uses AI to help create new affinity reagents...
Keep reading with a free account
The rest of this article, and every signal for Danaher, is in your free account.